HSCT
Showing 1 - 25 of 1,779
EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)
Recruiting
- EBV Infection After Allogenic HSCT
- EBV-TCR-T cells
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Nov 3, 2023
The Effecacy and Safety of Humanized CD25 Antibody in aGVHD Prophylaxis Among Elderly Patients After HID-HSCT Trial (CD25
Not yet recruiting
- The Effecacy and Safety of Humanized CD25 Antibody in aGVHD Prophylaxis Among Elderly Patients After HID-HSCT
- CD25 prophylaxis
- (no location specified)
Jun 20, 2023
Myeloid Leukemia, MDS Trial (IFN-?)
Not yet recruiting
- Myeloid Leukemia
- Myelodysplastic Syndromes
- (no location specified)
Nov 15, 2023
Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- Hematologic Malignancy
- CliniMACS®
- (no location specified)
Oct 17, 2023
Tumor, Caregivers Trial run by the National Institutes of Health Clinical Center (CC) (Sham VR, Active VR)
Not yet recruiting
- Neoplasm
- Caregivers
- Sham VR
- Active VR
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 26, 2023
Hematologic Malignancy, Stem Cell Transplant Complications Trial in Beijing (Beijing protocol)
Recruiting
- Hematologic Malignancy
- Stem Cell Transplant Complications
- Beijing protocol
-
Beijing, Beijing, ChinaDeparment of Hematology, Peking University People's Hospital
Jun 19, 2023
Tacrolimus Blood Concentration and Transplant-related Outcomes
Recruiting
- Graft Vs Host Disease
- +2 more
- TAC C/D ratio
-
Trieste, ItalyIRCCS Burlo Garofolo
Oct 6, 2023
Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)
Recruiting
- Acute Leukemia
- mitoxantrone liposome
- ATG
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Feb 13, 2023
Allogenic Stem Cell Transplantation Trial (SAR445419)
Not yet recruiting
- Allogenic Stem Cell Transplantation
- (no location specified)
Feb 13, 2023
Cytomegalovirus Infection Outcomes Among Hematopoietic Stem Cell
Not yet recruiting
- Cytomegalovirus (CMV)
- (no location specified)
Oct 11, 2022
Stress, Psychological, Caregivers Trial run by the National Institutes of Health Clinical Center (CC) (Stress reduction
Completed
- Stress, Psychological
- Caregivers
- Stress reduction intervention
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2023
Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia Trial in Suzhou (VEN+AZA+Modified BUCY)
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- Acute Lymphoblastic Leukemia
- VEN+AZA+Modified BUCY
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 10, 2023
Hematopoietic Stem Cell Transplantation, Bone Marrow Transplantation Trial (yoga or gentle massage plus standard treatment for
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- Bone Marrow Transplantation
- yoga or gentle massage plus standard treatment for HSCT
- (no location specified)
Nov 1, 2023
Hematopoietic Stem Cell Transplant (HSCT), Bronchiolitis Obliterans (BO) Trial in Cincinnati (Ruxolitinib)
Recruiting
- Hematopoietic Stem Cell Transplant (HSCT)
- Bronchiolitis Obliterans (BO)
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Aug 6, 2022
Acute Myeloid Leukemia Trial in Xuzhou (allogenic NK cells)
Recruiting
- Acute Myeloid Leukemia
- allogenic NK cells
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023
Prophylactic HQP1351 Therapy, Third Generation TKI Trial in Guanzhou (HQP1351( Olverembatinib dimesylate))
Withdrawn
- Prophylactic HQP1351 Therapy
- Third Generation TKI
- HQP1351( Olverembatinib dimesylate)
-
Guanzhou, ChinaDepartment of Hematology, Nanfang Hospital, Southern Medical Uni
Jan 16, 2023
Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- VEN+AZA+Modified BUCY
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 10, 2023
Leukemia Trial (Prehabilitation)
Not yet recruiting
- Leukemia
- Prehabilitation
- (no location specified)
Dec 5, 2022
MPS-IH (Hurler Syndrome) Trial in Worldwide (Experimental: OTL-203, Active Comparator: Allo-HSCT)
Not yet recruiting
- MPS-IH (Hurler Syndrome)
- Experimental: OTL-203
- Active Comparator: Allo-HSCT
-
Oakland, California
- +6 more
Nov 27, 2023
Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)
Not yet recruiting
- Leukemia, Myeloid, Acute
- +3 more
- Venetoclax plus RIC
-
Shanghai, Shanghai, ChinaShanghai General Hospital
Oct 12, 2022
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- +2 more
- Reduced-Intensity Conditioning Regimen
- Myeloablative Conditioning Regimen
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Jan 4, 2023
Brain Neuronal Networks, Chemosensory and Trigeminal Functions
Recruiting
- Hematopoietic Stem Cell Transplantation
-
Oslo, NorwayUniversity of Oslo
Aug 21, 2023
The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA Trial (Ruxolitinib 5 MG BID Oral Tablet)
Not yet recruiting
- The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
- Ruxolitinib 5 MG BID Oral Tablet
- (no location specified)
Jun 13, 2023
B-Cell Lymphoblastic Leukemia/Lymphoma Trial in Kunming (Anti-CD19 UCAR-NK cells)
Recruiting
- B-Cell Lymphoblastic Leukemia/Lymphoma
- Anti-CD19 UCAR-NK cells
-
Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
Dec 19, 2022